Management for premalignant lesions of the oral cavity

Aru Panwar, Robert Lindau, Aaron Wieland

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Premalignant lesions of the oral cavity present as visibly abnormal areas of mucosa and may be a source of significant anxiety for the patient and the clinician. Suspicious lesions should be biopsied to evaluate for dysplasia. The risk of malignant transformation may relate to patient characteristics, environmental risk factors and genetic alterations. Management of such lesions hinges on risk modification, surveillance, symptom management and directed biopsies. Excision or ablation of dysplastic lesions is indicated. We review the current evidence relating to management of premalignant lesions of the oral mucosa and make recommendations for practice patterns.

Original languageEnglish (US)
Pages (from-to)349-357
Number of pages9
JournalExpert review of anticancer therapy
Volume14
Issue number3
DOIs
StatePublished - Mar 1 2014

Fingerprint

Mouth
Mouth Mucosa
Mucous Membrane
Anxiety
Biopsy

Keywords

  • erythroplakia
  • leukoplakia
  • management
  • oral lichen planus
  • oral submucous fibrosis
  • premalignant

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Management for premalignant lesions of the oral cavity. / Panwar, Aru; Lindau, Robert; Wieland, Aaron.

In: Expert review of anticancer therapy, Vol. 14, No. 3, 01.03.2014, p. 349-357.

Research output: Contribution to journalReview article

Panwar, Aru ; Lindau, Robert ; Wieland, Aaron. / Management for premalignant lesions of the oral cavity. In: Expert review of anticancer therapy. 2014 ; Vol. 14, No. 3. pp. 349-357.
@article{3904f90466914c41bfdd32da410a974d,
title = "Management for premalignant lesions of the oral cavity",
abstract = "Premalignant lesions of the oral cavity present as visibly abnormal areas of mucosa and may be a source of significant anxiety for the patient and the clinician. Suspicious lesions should be biopsied to evaluate for dysplasia. The risk of malignant transformation may relate to patient characteristics, environmental risk factors and genetic alterations. Management of such lesions hinges on risk modification, surveillance, symptom management and directed biopsies. Excision or ablation of dysplastic lesions is indicated. We review the current evidence relating to management of premalignant lesions of the oral mucosa and make recommendations for practice patterns.",
keywords = "erythroplakia, leukoplakia, management, oral lichen planus, oral submucous fibrosis, premalignant",
author = "Aru Panwar and Robert Lindau and Aaron Wieland",
year = "2014",
month = "3",
day = "1",
doi = "10.1586/14737140.2013.842898",
language = "English (US)",
volume = "14",
pages = "349--357",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Management for premalignant lesions of the oral cavity

AU - Panwar, Aru

AU - Lindau, Robert

AU - Wieland, Aaron

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Premalignant lesions of the oral cavity present as visibly abnormal areas of mucosa and may be a source of significant anxiety for the patient and the clinician. Suspicious lesions should be biopsied to evaluate for dysplasia. The risk of malignant transformation may relate to patient characteristics, environmental risk factors and genetic alterations. Management of such lesions hinges on risk modification, surveillance, symptom management and directed biopsies. Excision or ablation of dysplastic lesions is indicated. We review the current evidence relating to management of premalignant lesions of the oral mucosa and make recommendations for practice patterns.

AB - Premalignant lesions of the oral cavity present as visibly abnormal areas of mucosa and may be a source of significant anxiety for the patient and the clinician. Suspicious lesions should be biopsied to evaluate for dysplasia. The risk of malignant transformation may relate to patient characteristics, environmental risk factors and genetic alterations. Management of such lesions hinges on risk modification, surveillance, symptom management and directed biopsies. Excision or ablation of dysplastic lesions is indicated. We review the current evidence relating to management of premalignant lesions of the oral mucosa and make recommendations for practice patterns.

KW - erythroplakia

KW - leukoplakia

KW - management

KW - oral lichen planus

KW - oral submucous fibrosis

KW - premalignant

UR - http://www.scopus.com/inward/record.url?scp=84896719098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896719098&partnerID=8YFLogxK

U2 - 10.1586/14737140.2013.842898

DO - 10.1586/14737140.2013.842898

M3 - Review article

C2 - 24559323

AN - SCOPUS:84896719098

VL - 14

SP - 349

EP - 357

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 3

ER -